• applepharmaceutical@gmail.com
  • Call Us: +91- 99877 11567


Brand : hepcvir
Composition : Sofosbuvir
Packing : 28 tablets
Strength : 400mg
Manufactured : cipla .

Buy Now


hepcvir is an active chemical component which is applicable in various brands. hepcvir is a nucleotide prodrug analogue; it is a NS5B polymerase inhibitor with HCV prohibiting activity.
hepcvir is available in the strength of 400mg and the dosage form of hepcvir is film coated tablet
hepcvir is not monotherapy; it should be combined with other retroviral medicines. The therapy should be followed for 12 weeks which results as curable


hepcvir indication for

hepcvir has prominent anti viral activity, which used to treats chronic hepatitis C viral infection. It is effective against hepatitis C of I, II, III and IV genotypes.

Safety points:

In hepatitis c treatment, monotherapy is not suggested, it is combinational therapy
The schedule and duration of the therapy should be depending upon the type of genotype of the virus and patient’s level.
The efficacy of the treatment depends on the virus and host characterization.

Pharmacology of hepcvir

hepcvir mechanism of action
hepcvir, an anti-viral medicine has nucleotide prodrug that prevents the replication of hepatitis C virus by prohibiting the effect of HCV NS5B RNA polymerase.
produce GS-461203, and form pharmacologically active triphosphate. uridine This enzyme go through intercellular metabolism to
Hepatitis C virus NS5B RNA polymerase infused this metabolite into viral DNA, it acts as chain end.



hepcvir is absorbed rapidly after oral administration
The peak plasma concentration of hepcvir and circulating metabolite GS-331007 occurs at 0.5 to 2 hours and 2 to 4 hours respectively after administration

Effect of Food:

hepcvir with high fat meals, causes reduction in absorption rate of the hepcvir when compared with fasting
Whereas high fat meals do not creates effect when exposed to metabolite GS-331007. So it is not consider whether hepcvir takes with or without food


hepcvir is highly bound to blood plasma protein approximately 61-65%. The GS-331007 binding to plasma proteins is minimal.


hepcvir is highly metabolized in liver and to form nucleoside triphosphate analogue which is active (GS-461203).
The activation metabolic of route is associates sequential hydrolysis of a carboxylic acid ester molecule with cathepsin A or carboxyl esterase 1.


The elimination of route in metabolites occurs via Kidneys, intestines, and lungs The drug around 78% excreted as inactive metabolite, 3.5% was excreted as hepcvir
The half life time of both hepcvir and GS-331007 is 0.4 and 27 hours respectively.

In the treatment of chronic hepatitis C infection;
hepcvir should be combined with ribavirin or pegylated interferon and ribavirin. Combinational therapy: The usual prescribed dose of hepcvir is one tablet 400mg should be taken as a single dose, disregarding of food intake.
HCG (genotype I and IV: hepcvir + peg interferon alfa + ribavirin followed for 12 weeks
HCG genotype II: hepcvir + ribavirin for 12 weeks HCG genotype III: hepcvir + ribavirin for 24 weeks Ribavirin dose should be recommended on the basis of weight of the patient. It is administered orally with food.
In the condition of renal failure, ribavirin should be discontinued. There is a chance to get re-infection of HCV after transplantation; in this condition hepcvir with ribavirin is recommended it is not more than 48 weeks.

Peg interferon dosage regimen: for
Peg interferon alpha 2a: 180 mcg SC weekly Peg interferon alpha 2b: 1.5mcg/kg/week SC, not exceed to 150mcg/week

Ribavirin dosage regimen: for
For prevention of post transplant HCV re-infection: hepcvir + ribavirin for 48 weeks or until liver transplant.
It should be taken with food
<75 kg: 500mg PO twice daily, ≥75 kg: 600mg PO twice daily

Pediatric dose:
For hepatitis C viral infection
<12 years or <35 kg: the safety and efficacy of the drug has not been established
≥12 years or weight ≥35 kg: 400mg PO qDay with weight based ribavirin
During combination with ribavirin, it must be taken with food. hepcvir should be taken with or without food

Amiodarone: symptomatic bradycardia occurs while taking hepcvir with amiodarone. This combination causes serious cardiac arrest. Some other drugs like;
symptomatic bradycardia occurs while taking hepcvir with amiodarone. This combination causes serious cardiac arrest. Some other drugs like;
Atazanavir; cobicistat: cobicistat is an inhibitor of transporters P-glycoprotein inducers and BCRP. In combination with hepcvir leads to increase its concentration; adverse affects may produce.
Apalutamide is a P-glycoprotein inducers and BCRP. It should not be combined with hepcvir, these concomitant can cause reduction of plasma concentration of hepcvir and loss of anti-viral efficacy.

While using combinational therapy there is a possibilities of contraindication;
With peg-interferon
Autoimmune hepatitis, decompensated liver disease For neonates and infants

Drugs like rifampin and st. John s wort are potent P-gp inducers leads to reduce plasma concentration of hepcvir.
Peg interferon:
Caution in renal impairment patient
Liver transplantation
Cause Myelosuppression
Flu like symptoms
Hepatic impairment

Hypersensitivity, Pregnant women or become pregnant
Pancreatitis, Thalassemia major, sickle cell anemia Concomitant with Didanosine
Autoimmune hepatitis, decompensated liver disease, For neonates and infants
While combined with ribavirin care should be taken, because it causes fetal harm or death. Ribavirin not recommended in pregnancy period.
Hemolytic anemia, Anemia, Ocular disorders, Carcinogenic effects, Bone marrow suppression

Common side effects of hepcvir

<1% has chances to get; Neutropenia, Pancytopenia, Severe depression, Bradycardia, Some healthcare professionals;
Both ribavirin and peg interferon has some adverse effects;
Based on pharmacological effects;
>10% of the patient may have chance to get adverse effects while taking hepcvir and ribavirin (12 weeks) like;
Nausea, Insomnia, Pruritus, Fatigue, Headache,


Pregnancy and lactation:

hepcvir is comes under the pregnancy category: B.
But when combined with ribavirin category should be X Ribavirin causes fetal death
Concomitant with ribavirin and peg interferon, it is not recommended in breastfeeding mothers.


hepcvir is generally stored at room temperature below 30°c (86°F)
It should be keep away from moisture, heat, and light
Keep reach out from children and pets

Missed dose:

Once patient fail to administer the dose of hepcvir, must consult with medical practitioner and take the missed dose. Otherwise it should be skipped and follow the next drug schedule.
Do not double the dose.


sofosbuvir400mg.com is a fully licensed and regulated pharmacy, takes all precautions to strictly abide by the laws and regulations set forth in the dispensing of prescription medications. By placing the order for your prescription medicines, you acknowledge and accept the following terms regarding the purchase of any prescription medicines.
sofosbuvir400mg.com will not dispense any prescription medication without a valid prescription from a licensed physician.
If you are ordering prescription medication(s), you hereby confirm that you will send us a scanned copy of your valid prescription(s) via email, fax, Whatsapp, or by post, and this prescription shall then be subject to the scrutiny of and approval by our qualified Pharmacists
The drug information provided in the sofosbuvir400mg.com is for informative purposes only and this Website is not intended to provide diagnosis, treatment or medical advice. We are not liable for any adverse effects or harm to you as a result of your reliance on the information in the Website.
sofosbuvir400mg.comrequires either the User or Customer or the Caregiver to confirm he/she is completely aware of the indications, side effects, drug interactions, effects of missed dose or overdose of the medicines he/she orders from us. It is imperative to seek professional advice from your physician before purchasing or consuming any medicine from sofosbuvir400mg.com
sofosbuvir400mg.com is a Caregiver can order prescription medicines on your behalf..


This information should not be used to decide whether or not to take this Product or any other medicine. Only the healthcare provider has the knowledge and training to decide which medicines are right for a specific patient. This information does not endorse any medicine as safe, effective, or approved for treating any patient or health condition. This is only a brief summary of general information about this Product . It does NOT include all information about the possible uses, directions, warnings, precautions, interactions, adverse effects, or risks that may apply to this product. This information is not specific medical advice and does not replace information you receive from the healthcare provider. You must talk with the healthcare provider for complete information about the risks and benefits of using this product.